AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation With the Schall Law Firm
Aardvark Therapeutics IncAardvark Therapeutics Inc(US:AARD) Businesswire·2026-02-28 16:46

Group 1 - Aardvark Therapeutics, Inc. is currently under investigation for potential fraud, providing an opportunity for investors to join the legal proceedings with the Schall Law Firm [1] - The investigation may impact the company's reputation and financial standing, raising concerns among current and potential investors [1] - The Schall Law Firm is actively seeking investors who may have been affected by the alleged fraudulent activities to participate in the investigation [1]